Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) Profit After Tax (2017 - 2020)

enVVeno Medical has reported Profit After Tax over the past 4 years, most recently at -$4.4 million for Q4 2020.

  • Quarterly results put Profit After Tax at -$4.4 million for Q4 2020, down 90.94% from a year ago — trailing twelve months through Dec 2020 was -$9.1 million (down 19.8% YoY), and the annual figure for FY2025 was -$19.5 million, up 10.76%.
  • Profit After Tax for Q4 2020 was -$4.4 million at enVVeno Medical, down from -$2.0 million in the prior quarter.
  • Over the last five years, Profit After Tax for NVNO hit a ceiling of -$1.2 million in Q1 2020 and a floor of -$5.0 million in Q2 2018.
  • Median Profit After Tax over the past 4 years was -$1.9 million (2019), compared with a mean of -$2.4 million.
  • Biggest five-year swings in Profit After Tax: tumbled 303.98% in 2018 and later soared 66.85% in 2019.
  • enVVeno Medical's Profit After Tax stood at -$3.1 million in 2017, then soared by 42.97% to -$1.8 million in 2018, then dropped by 28.58% to -$2.3 million in 2019, then plummeted by 90.94% to -$4.4 million in 2020.
  • The last three reported values for Profit After Tax were -$4.4 million (Q4 2020), -$2.0 million (Q3 2020), and -$1.6 million (Q2 2020) per Business Quant data.